NEW YORK (GenomeWeb) – CombiMatrix reported after the close of the market on Thursday a 28 percent jump in first quarter revenues, an increase driven by growing sales of both its microarray and non-microarray diagnostics tests.

For the three-month period ended March 31, CombiMatrix's revenues rose to $2.3 million from $1.8 million in the same period a year earlier, matching analysts' average estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.